• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.

作者信息

Gentil Govantes M A, Gómez Ullate P, Errasti P, Fernández Fresnedo G, Capdevila L, Sanz Guajardo A, Cubero J J

机构信息

H. Virgen del Rocico, Sevilla, Spain.

出版信息

Transplant Proc. 1998 Aug;30(5):1658-9. doi: 10.1016/s0041-1345(98)00380-7.

DOI:10.1016/s0041-1345(98)00380-7
PMID:9723231
Abstract
摘要

相似文献

1
Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Transplant Proc. 1998 Aug;30(5):1658-9. doi: 10.1016/s0041-1345(98)00380-7.
2
A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
Transplant Proc. 1998 Aug;30(5):1666-7. doi: 10.1016/s0041-1345(98)00384-4.
3
Neoral versus Sandimmune in kidney transplantation.肾移植中，新山地明与环孢素的对比
Transplant Proc. 1998 Aug;30(5):1749-50. doi: 10.1016/s0041-1345(98)00414-x.
4
Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.肾移植受者从山地明转换为新山地明：两年经验
Transplant Proc. 1998 Aug;30(5):1753-5. doi: 10.1016/s0041-1345(98)00416-3.
5
Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
Transplant Proc. 1996 Aug;28(4):2259-61.
6
Conversion from Sandimmune to Neoral in patients with stable renal allograft function: UHKL experience.肾移植功能稳定患者从山地明转换为新山地明：香港大学深圳医院的经验。
Transplant Proc. 1998 Nov;30(7):3535-6. doi: 10.1016/s0041-1345(98)01126-9.
7
Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.肾移植患者中，环孢素微乳剂与传统环孢素安全性及耐受性的随机、双盲、为期一年的研究。国际山地明新山地明研究组
Transplantation. 1998 Jun 15;65(11):1455-60. doi: 10.1097/00007890-199806150-00008.
8
Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
Transplant Proc. 1996 Dec;28(6):3138-9.
9
Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Transplant Proc. 1996 Dec;28(6):3140-1.
10
Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune.肾移植患者从赛尼哌转换为赛贝（Sang-35）后的9个月随访
Transplant Proc. 1999 Feb-Mar;31(1-2):324-5. doi: 10.1016/s0041-1345(98)01646-7.

引用本文的文献

1
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述
Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.